About this episode

Dr. Saland summarizes the main findings from his study on the ILLUMINATE-A trial results.

Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.

People in this episode

Guest: Dr. Saland

Topics covered

• clinical trial
• nephrology
• hyperoxaluria
• lumasiran
• medical research

Keywords

• ILLUMINATE-A
• Lumasiran
• Primary Hyperoxaluria
• clinical trial results
• nephrology

Mentioned in this episode

Products: Lumasiran

Books & works: ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1

Places: Primary Hyperoxaluria Type 1

More episodes of Clinical Journal of the American Society of Nephrology (CJASN)

• Total Kidney Volume and eGFR in Polycystic Kidney Disease · May 18, 2026 · 4 min
• Finerenone and eGFR Slope · February 26, 2026 · 3 min
• Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure · February 18, 2026 · 4 min
• Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients · December 18, 2025 · 6 min
• Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD · October 28, 2025 · 4 min
• SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease · September 30, 2025 · 4 min

Explore listener stats, chart rankings, contacts and more on the Clinical Journal of the American Society of Nephrology (CJASN) podcast page.